Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha.
van Lieshout
Antoine W T
AW
Creemers
Marjonne C W
MC
Radstake
Timothy R D J
TR
Elving
Lammy D
LD
van Riel
Piet L C M
PL
D000068879:Adalimumab; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006111:Graves Disease / Q000175:diagnosis* / Q000209:etiology*; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab